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The calcium transients associated with contraction in
human working myocardium were recorded by use of
the bioluminescent protein, aequorin, a substance that
emits light when it combines with calcium ion (Ca + "),
Small amounts of aequorin were microinjected into su-
perficial cells of human atrial and ventricular muscle
obtained from tissue routinely excised and discarded at
the time of cardiac surgery. Light output, an index of
intracellular Ca + ", and isometric tension development
were recorded at 37.SoC at 1 to S second intervals of
stimulation. Light increases much more quickly than
tension and decreases toward basal levels by the time
Beginning with Sidney Ringer's demonstration in 1883 (1)
that calcium (Ca + +) ions are required for cardiac muscle
contraction, a large body of experimental evidence (2) has
accumulated which indicates that Ca + + plays a central role
in the process of excitation-contraction coupling in the heart .
For many years , our ability to study the intracellular Ca + +
fluxes that occur during cardiac contraction and relaxation
has been hindered by the lack of a suitable intracellular
Ca + + indicator. This limitation has been overcome to a
large extent by the introduction of aequorin , a biolumines-
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that peak tension is reached. The configuration and time
course of the aequorin signal in human myocardium and
its responses to inotropic interventions are similar to
those recorded in lower mammalian species. The calcium
transient appears to be dominated by the release and
uptake of Ca + + from intracellular stores under all con-
ditions studied.
These results indicate that aequorin is a useful tool
for studying the effects of drugs and disease states on
cardiac excitation-contraction coupling in human beings
as well as in lower animals.
cent protein that emits light when it combines with Ca + + .
Although other methods for measuring Ca + + are available,
including the metallochromic and fluorescent indicators and
Ca + + -selective electrodes, bioluminescent indicators like
aequorin have several advantages for use in physiologic
systems; these have recently been presented in detail by
Blinks et al. (3) . Aequorin is suitable for measurement of
intracellular Ca + + in a variety of different types of cell s,
including actively contracting cardiac muscle . Calcium tran-
This article is part of a new series of informal teaching
reviews devoted to subjects in basic cardiology that are of
particular interest because oftheir high potentialfor clinical
application . The series is edited by Arnold M . Katz. MD.
FACC. a leading proponent of the view that basic science
can be presented in a clear and stimulating fashion . The
intent of the series is to help the clinician keep abreast of
important advances in our understanding of the basic mech-
anisms underlying normal and abnormal cardiac function .
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sientshave beenrecordedwithaequorin in frog atrial muscle
(4), ventricular strips from Amphiuma tridactylum (5,6),
canine Purkinjefibers (7-9) and papillarymusclesand strips
of trabeculae cameae from the cat, ferret. rat and rabbit
(10-14). The present study confirms the similarity of the
calcium transients obtained in human working myocardium
to those of lower mammalian species (15).
Methods
Aequorin Solution. Aequorin was extracted, purified and
preparedfor injectionaccordingto techniquesthat have been
described elsewhere in detail (16). It was dissolved to a
concentration of 1 to 5 mg/ml in a solution containing 150
roM KCI and 5 roM HEPES (2-[N-2-hydroxyethylpiperazin-
N'-vl] ethanesulfonic acid) buffer, pH 7.5. The aequorin
solution was loaded into fine-tipped micropipettes through
which potential was monitored to determine when cells had
been penetrated, and injected by the applicationof gas pres-
sure (17,18).
Myocardial tissue preparations. Stripsof humanatrial
pectinate muscles, ventricular trabeculae cameae and ac-
cessory papillary muscles were obtained from tissue re-
moved and discarded at the time of routine cardiac surgery.
At the time of removal, tissue samples were placed into an
insulated container of oxygenated physiologic salt solution
(see composition below) and transported rapidly to the lab-
oratory. Muscles I mm or less in diameter were selected
for these experiments . Aequorin was microinjected into a
large numberof superficial cells of each preparation; it was
usually necessary to inject 50 to 100 cells to obtain satis-
factory signals. The muscles were maintained in a bicar-
bonate-buffered physiologic salt solution with the following
composition: (roM) Na+, 140;K+, 5; Ca+ +.2.25; Mg" +,
I; Cl. 103.5; HC03 ~. 24; P04=, 1.0; S04=' I; acetate.".
20; glucose, 10. The physiologic salt solution was equili-
brated with 95% oxygen and 5% carbon dioxide and had a
pH of 7.4. Observations were made at 37.5°C.
Measurements. After microinjection. the muscles were
transferred to a speciallydesigned light collecting apparatus
(18), and the light emitted by the injected aequorin was
recorded with a photomultiplier (EMI 9635B). Because the
light levels were very low and photomultiplier shot noise
was prominent, it was necessary to average successive sig-
nals (from 16 to several hundred, depending on light inten-
sity) to obtain a satisfactory signal to noise ratio. Light
output and isometric tension development were recorded
from muscles stimulated to contract with 5 ms pulses at
threshold voltage delivered through a punctate cathode.
Results (Fig. 1 to 6)
Figure 1 shows the light (an index of intracellularCa++)
and tension signals recorded from a human right atrial pec-
tinate muscle, while Figure 2 shows similar recordings in
500
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Figure l. Aequorin signal (noisy trace) and tension response
(smooth trace) recorded from a human right atrial pectinate mus-
cle . Each trace represents the average of 128 responses at 1 second
intervals of stimulation. The symbol k denotes thousands of photon
counts per second. The bottom of the light calibration bar in-
dicates the rest light level between contractions . The lower trace
is the stimulus artifact. In this figure and in each of the following
figures. the records were made at steady state .
ventricularmuscle from the cat, rabbit and dog. In all prep-
arations, the aequorin signal consists of a single component
that increases much more rapidly than does tensionand then
decreases toward basal levels by the time that peak tension
is reached. Isoproterenol produced a dose-dependent in-
crease in both the light and tension developed by a human
left ventricular preparation (Fig. 3). In addition , it led to
an abbreviation of the light and tension signals (Fig. 4).
Theophylline also increased the light and tension re-
sponses of an aequorin-injected right atrial pectinatemuscle
(Fig. 5). Although theophylline produced a dose-related
increase in the amplitudes of the light and tension signals.
the relative increase in peak light compared with peak ten-
sion was less than with isoproterenol. Unlike isoproterenol,
theophylline markedly prolonged both the aequorin signal
and the corresponding contraction (Fig. 6).
Discussion
Use of Aequorin as an Intracellular Calcium
Indicator in Cardiac Muscle
An understanding of the role of intraceIlular Ca++ tran-
sients in the regulation of cardiac contraction depends on
our ability to measure these transients and relate changes in
force to changes in Ca++ concentration (18.19). One of
the mostpromisingtechniquesfor obtainingthis information
involves the use of aequorin, a Ca" +-sensitive biolumi-
nescent protein that is extracted from the luminescent jel-
lyfish, Aequorea forskalea . Aequorin emits a blue light in
the presence of Ca + + ions; no other cofactors are required
for this reaction, which is specific for Ca t + under biologic
conditions. The Ca++ sensitivityof aequorin makes it weIl
suited for the detection of Ca ++ over the physiologic range
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Figure 2. Aequorin signals and tension responses (as in Fig. I)
recorded from cat, rabbit and dog right ventricular papillary mus-
cles microinjected with aequorin. Preparations were stimulated to
contract at I second intervals; cis denotes photon counts per second.
found in heart muscle (1 X 1O-7t04 X 1O-6M)(3). Kinetic
studies (20) have shown that the luminescent reaction is
sufficiently rapid to record Ca + + transients in cardiac cells
without causing significant aberration of their time courses.
A major advantage of aequorin in the study of muscle
cells is that the light signal is relatively free of motion
artifact; therefore, aequorin is well-suited for recording Ca+ +
transients in actively contracting cells. The preparation of
aequorin for laboratory use and the kinetics of its reaction
with Ca" + have been described (3,21). Aequorin has been
successfully introduced into the cytoplasm of a variety of
Figure 3. Influence of isoproterenol on the aequorin signal and
tension developed by a human left ventricular accessory papillary
muscle. Numbers in individual panels indicate molar concentra-
tions of isoproterenol. Stimulus interval = 4 seconds; 32 signals
averaged.
cell types by the microinjection technique (3), although its
use in myocardial cells has been hampered by the small size
of these preparations. In spite of this limitation, Ca + + tran-
sients have been recorded in a variety of cardiac tissues
injected with aequorin (4,8,10-14). The present study de-
scribes the first successful application of this technique to
the working myocardium of human beings.
Problems associated with microinjectioil tech-
niques. The methodsand pitfalls of the microinjection tech-
nique in multicellularcardiac musclepreparations have been
described in detail (16). A major concern is whether the
superficial cells are injured or killed by the microinjection
process. In the present study, the resting membrane potential
was monitored during and after the injection of each cell.
After several pulsed pressure injections of aequorin had been
administered, the resting potentials in the majority of cells
were not significantly changed from the control, indicating
that cellular integrity was maintained. Furthermore, it is
well known that microelectrode puncture sites in the surface
membranes of cardiac muscle cells can reseal after removal
of the electrode (22). However, there is no more definitive
way of answering this important question at the present time
J
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Figure 4. Influence of isoproterenol (iso. ) on the
time course of the light and tension responses on
the preparation shown in Figure 3. Tracings re-
corded before (arrows) and after administration of
drug are superimposed with vertical scales adjusted
togivethe same peak. True amplitudesare indicated
on the right. cont. = control.
SO that the possibility that some partially depolarized or
otherwise injured cells contribute to the overall light re-
sponse cannot be absolutely ruled out. Assuming that the
superficial cells do function normally, the light responses
from these cells should be indicative of Ca + + transients in
the preparation as a whole, if potential problems with dif-
fusion of drug, oxygen and metabolic products to and from
the core of the muscle are minimized by utilizationof prep-
arations of 1 mm or less in diameter.
Another major concern is whether aequorin is uniformly
distributed throughout the cell. A relatively small protein
such as aequorin (molecular weight approximately 20,000)
wouldbe expected to havea uniformdistributionthroughout
thesarcoplasm, and recentstudies in isolatedskeletalmuscle
fibers (23) indicate that after microinjection, aequorin dis-
tributes uniformly across the width of the cell. However, it
has not yet been possible to carry out confirmatory exper-
iments in multicellular preparations of cardiac muscle.
Nonlinearity of aequorin light response. Interpretation
of aequorin light signals is complicated by the nonlinearity
of the aequorin light response, which is directly proportional
to the photoprotein concentration but increases as a power
of the free calciumconcentration, that is, as ICa+ + In . Over
the range of Ca+ + concentrations relevant to the experi-
ments described in this report, n = 2.5; thus, a 5.7-fold
increase in light would be produced by a 2-fold increase in
the Ca+ + concentration. An important consequence of this
nonlinear relation is that if the Ca + + ion concentration is
notuniform in a given cell, the intensity of the lightemission
will be higher than if the same amount of Ca+ + were dis-
tributed uniformly. In other words, the amplitude of the
aequorinsignal will be dominatedby regions of the cell that
contain the highest Ca+ + concentrations (that is, entry and
release sites) and, except under conditions such as tetanus
when the intracellularCa+ + concentration reaches a steady
state. does not necessarily reflect the Ca+ + concentration
immediately surrounding the myofilaments. For this reason,
the aequorin signals recorded in these experiments cannot
be translated into exact Ca+ + concentrations.
Aequorin molecules are discharged in the course of the
luminescent reaction; however, only a small portion of the
aequorin initially injected is actually consumed during the
course of an experiment because light responses reaching
at least 50% of control intensity have been obtained up to
72 hours after injection in cat papillary muscle preparations
continuously stimulated to contract at 4 second intervals.
Despite these potential problems, aequorin is the most
useful substance currently available for monitoring intra-
cellular Ca+ + transients in actively contracting cells and
has providedthe first direct recordings of intracellularCa+ +
transients in the heart (3).
Interpretation of the Aequorin Signal
Our present model of excitation-contraction coupling in
the heart can be divided into four steps (Fig. 7) (24):
I . An action potential depolarizes the sarcolemma.
2. This depolarization releases Ca+ + from the subsar-
colemmalcisternae of the sarcoplasmic reticulumand
allows entry of Ca+ + from outside the sarcolemma,
or both.
3. Calcium ions diffuse to the troponin-C on the thin
filaments and, by a complex sequence of events, the
binding of Ca+ + to this regulatory protein permits
actin and myosin to interact.
4. Relaxation occurs when the sarcoplasmic reticulum
reaccumulates the calcium ions, causing Ca+ + to dis-
sociate from troponin-C.
The cellular mechanisms involved in each step are still not
completely understood and in some cases remain subject to
considerable controversy (25,26). Several excellent reviews
consider various aspects of the excitation-contraction cou-
pling process in detail (24,27- 34).
Amplitude and time course of Ca + + transient. The
intracellular Ca+ + transient that is recorded with aequorin ,
which reflects steps 2 to 4 in this analysis of excitation-
contraction coupling, can be considered in terms of its am-
plitude and time course. The Ca + + contributing to the am-
plitude of the aequorin light response may be derived from
several different sources: the extracellular space, the gly-
cocalyx of the sarcolemma, the sarcoplasmic reticulumand,
under certain circumstances, the mitochondria (33). On the
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FigureS. Influence of theophylline onaequorin signal and tension
development of a human right atrial pectinate muscle. Numbers
in individual panels indicate concentrations of theophylline (mM) .
Stimulus interval = 5 seconds; 256 signals averaged.
basisof data obtainedwith skinnedmammalian cardiac mus-
cle preparations, the sarcoplasmic reticulum appears to be
the major source of the Ca + + involved in activation of the
myofilaments. In rat, cat, dog, human and rabbit myocar-
dium, Ca+ + influx across the sarcolemmaduring the action
potential releases a quantitatively larger concentration of
Ca+ + (around 20-foldgreater in rats) fromthe sarcoplasmic
reticulum by means of a "Ca + + -induced Ca+ + release"
process (32). The mitochondria appear not to playa role in
the beat to beat regulation of myoplasmic Ca+ + unless the
intracellular Ca+ + becomes extremely high (33).
In terms of the simplified model of excitation-contraction
coupling outlined above. Ca+ + entering the cell from the
extracellular space and Ca+ + released from the sarco-
plasmic reticulum would both be expected to contribute to
the amplitude of the light response. However, the quantity
of Ca+ + released from the sarcoplasmic reticulum during
a single cardiac contraction is many times greater than that
entering the sarcoplasm from the extracellular space. For
this reason, it is probable that the amplitudeof the aequorin
light response in mammalian ventricular muscle predomi-
nantly reflects the amount of Ca+ + released by the sarco-
plasmic reticulum (35,36). The time course of the light
transient can be influenced by several factors, including the
rate of entry of Ca+ + into the sarcoplasm, the rate of Ca+ +
diffusion and binding to the myofilaments and the rate of
Ca+ + reaccumulation from the sarcoplasm and myofila-
ments by the sarcoplasmic reticulum during relaxation. The
sacroplasmic reticulum is the major site of both Ca+ + re-
lease and reaccumulation during the normal cardiac cycle
(37); therefore, the time course of the light transient would
largely reflect Ca" + handling by these membranes (12,38).
Patterns of Light and Tension Responses
Components of the light response. Three different
components of the light response have been analyzed in
theseexperiments. The peak light is a measureofthe amount
of Ca+ + released by the sarcoplasmic reticulum. The time
to peak light appears to reflect the relative balance between
the phaseof the Ca+ + transientduring which Ca+ + release
predominates (ascendingphase) and the phase during which
resequestration of Ca+ + predominates (descending phase).
The half-time for decline of the light signal reflects mainly
the speed of Ca+ + uptake by the sarcoplasmic reticulum.
These interpretations of the componentsof the light transient
are undoubtedly oversimplifications of the complex series
of events that occur during excitation-contraction coupling
in the heart, but are consistent with our current understand-
thea. 10 mM
2.4 9
theo. 10 mMJ\
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conI. ~~_ conI.
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Figure 6. Influence of theophylline (theo.) on the
time course of the light and tension responses on
the preparation shown in Figure 5. Tracings re-
corded before and after (arrows) administration of
drug are superimposed with vertical scales adjusted
togive the same peak. True amplitudes areindicated
on the right. cant. = control.
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Table 2. Subcellular Actions of Inotropic Agents on
Intracellular Ca + + Handling and Proposed Mechanisms
of Action
Release Reuptake Sensitivity of
Pattern From Stores by Stores Myofilaments
I t t t t t ~
II ~ t ~ ~ t
Ca··
+
INTRACELLULARCs" STORES
(SARCOPLASMIC RETICULUM)
CONTRACTIO~ ~ELAXATI0N
MYOFILAMENTS
Figure 7. Major steps of excitation-contraction coupling in mam-
malian working myocardium.
III
IV
t t
i t t ?
Proposed
Mechanisms
t cAMP
i cGMP.
t cAMP.
"direct"
effects
i Loading of
Ca' + stores
Unknown
ing of the Ca + + movements in the myocardial cell and form
the basis for an empirically useful model for analysis of
Ca + + transients.
Components of the tension response. The tension shown
in this and other reports can also be analyzed with regard
to peak tension, time of peak tension, and the half-time of
relaxation from peak tension, allowing a large number of
inotropic agents to be evaluated in aequorin-injected cat
papillary muscles. The results of these studies show that the
actions of drugs on the amplitudes and time courses of the
light and tension responses produce four distinct patterns
(Table I). These patterns are consistent with known actions
of the various agents on the release of Ca + + from intra-
cellular stores, rate of Ca + + uptake by the sarcoplasmic
reticulum and Ca + + -sensitivity of the myofilaments (Table
2) (12,15,38-40). Agents producing Pattern I include beta-
agonists, increased frequency of stimulation, papaverine,
cholera toxin, isobutylmethylxanthine and dibutyryl cyclic
adenosine monophosphate (AMP); Pattern II, theophylline
and caffeine; Pattern III, digitalis, increased [Ca + +] and
vanadate; Pattern IV, amrinone.
Pattern I (isoproterenol). Figures 3 and 4 show that
the positive inotropic effect of isoproterenol in human work-
ing myocardium is accompanied by a decrease in the time
to peak tension and the half-time of relaxation from peak
tension. These changes in the amplitude and time course of
Table 1. Four Patterns of Light and Tension Responses
Produced by Positive Inotropic Agents in the Cat
Papillary Muscle
Light Tension
Time Time
Pattern wi Example Peak to Peak Til, Peak to Peak Til,
I. isoproterenol t t t ~ ~ ~ t t t ~ ~ ~ ~
II, theophylline ~ t t t t t t t t t t t t
III. digitalis t t ~ ~ t t ..... ~
IV. amrinone t t t ~ t t ~ ~
T'I, = half-time for declinefrom peak; t = increase; ~ = decrease;
<-+ = no change. The number of arrows indicates the relative maximal
change or rate of change of each variable.
cAMP = cyclic adenosine monophosphate; cGMP = cyclic guanine
monophosphate.
the isometric contraction are paralleled by similar changes
in the aequorin signal, that is, increases in peak light and
abbreviations of the time course of the light transient. These
results indicate that the rate of Ca + + release into the sar-
coplasm, and the quantity of Ca + + released, are both in-
creased by isoproterenol. In addition, the decreased half-
time of decline from peak light suggests that the rate of
Ca + + accumulation by the sarcoplasmic reticulum is
increased.
These findings are consistent with current models that
attribute many of the cardiac effects of beta-adrenoceptor
agonists to activation of cyclic AMP-dependent protein kin-
ases and subsequent phosphorylation of the sarcolemma,
sarcoplasmic reticulum and myofilaments (41,42). Phos-
phorylation of sarcolemmal proteins may account for the
increase in the slow inward (calcium) current that has been
observed in the presence of beta-agonists (37,42,43), while
phosphorylation of phospholamb an , a regulatory protein of
the sarcoplasmic reticulum, by a cyclic AMP-dependent
protein kinase accelerates both Ca + + release and reaccu-
mulation and increases stored Ca + + (37,42). An increase
in intracellular cyclic AMP also leads to a decreased Ca + + -
sensitivity of the myofilaments (44) that appears to result
from phosphorylation of troponin-I by a cyclic AMP-de-
pendent protein kinase (37,42). The increased sarcoplasmic
reticulum Ca + + stores and release caused by phosphory-
lation of phospholamban can account for the increased peak
light, while the increased rate of Ca + + uptake by the sar-
coplasmic reticulum and increased rate of dissociation of
Ca + + from troponin-C can explain the decreased half-time
of decline from peak light observed after isoproterenol
administration.
In previous studies on the cat papillary muscle, several
other drugs known to increase intracellular cyclic AMP lev-
els were evaluated. These included cholera toxin (45), iso-
butylmethylxanthine (46), papaverine (46) and dibutyryl
cyclic AMP (41); each produced effects similar to isopro-
terenol (12,38). These findings support the grouping of drugs
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that increase intracellular cyclic AMP levels into a distinct
class of inotropic agents.
Pattern II (theophylline). Methylxanthines (caffeine,
theophylline, theobromine and isobutylmethylxanthine)
increase intracellular cyclic AMP levels via inhibition
of phosphodiesterase (46). In the cat papillary muscle, the
effects of isobutylmethylxanthine on the light and tension
responses are the same as those of isoproterenol; however
most other methylxanthines (for example, caffeine, theoph-
ylline, theobromine) also inhibit Ca + + uptake by the sar-
coplasmic reticulum (47). This inhibition of Ca" + uptake
reduces the releasable stores of Ca + + in the sarcoplasmic
reticulum (48), and so contributes to the characteristicchanges
in the amplitudes and time courses of the light and tension
responses shown for theophylline in Figures 5 and 6. Al-
though these figures show the peak tension to be increased
in a dose-related manner by theophylline, the relative in-
crease in peak light compared with peak tension was less
than with isoproterenol. This result may be explained by
recent findings which show that theophylline, and presum-
ably caffeine and theobromine, actually increase the Ca + +
sensitivity of the myofilaments (49,50). Hence, although
the peak concentration of Ca + + available at the level of the
myofilaments may be reduced by these drugs, any given
Ca + + concentration will produce a greater degree of con-
tractile activation. The finding that the overall duration of
the Ca + + transient was always prolonged compared with
the control accounts for the greatly prolonged half-time of
decline from peak tension. These data thus show that the
duration of the Ca + + transient is an important determinant
of the time course of tension development and may also
contribute to the positive inotropic effect of a drug like
theophy lline.
Patterns III and IV (digitalis and amrinone). Two
additional patterns of responses have been identified in cat
papillary muscles injected with aequorin. Pattern /II re-
sponses. These are produced by an increase in extracellular
Ca + + and a heterogeneous group of drugs that includes the
cardiac glycosides and ammonium vanadate. Although these
agents are influenced by different mechanisms, their com-
mon effect is to increase loading of intracellular Ca + + stores
without affecting the time course of intracellular Ca + +
movements. For example, our current understanding of the
mechanism of inotropic action of the cardiac glycosides can
be summarized as follows: inhibition of (Na, K) adenosine
triphosphatase (ATPase) reduces the Na + concentration
gradient across the cell membrane which reduces the mag-
nitude of exchange-coupled Ca + + efflux; the overall effect
is to increase the net intracellular Ca + + concentration (51).
This increased intracellular Ca + + becomes available to load
intracellular stores which in tum, makes more Ca + + avail-
able for release during subsequent contractions, and thereby
increases contractility. The cardiac glycosides appear to have
no significant direct effects on the intracellular mechanisms
involved in excitation-contraction coupling, although they
may increase inward Ca + + currents during the plateau phase
of the action potential (52,53). This is consistent with the
results of aequorin studies which indicate that these drugs
have no significant effect on the time course of the devel-
opment of light and tension responses, except in toxic
concentrations.
Pattern IV. The effects of amrinone on light and tension
development are clearly different from those of the other
agents studied and define a fourth pattern of response. Am-
rinone is a newly introduced inotropic agent that acts by an
unknown mechanism, Studies have shown that effective
doses of amrinone do not act via the beta-adrenergic or
histamine receptors, do not appear to modulate cyclic AMP
levels and do not inhibit (Na,K) ATPase activity (54). This
information indicates that the mode of action of amrinone
may be quite different from that of other inotropic drugs,
although a recent report indicates that amrinone' s inotropic
action may be related to inhibition of phosphodiesterase
(55-57). Table I shows that amrinone produced a marked
increase in the amplitude of the aequorin light signal in
conjunction with increased tension, which indicates that its
positive inotropic effect is associated with an increase in
the concentration of intracellular Ca + +. The time to peak
light was usually prolonged, and may represent an increased
duration of release of Ca + + into the sarcoplasm. A decrease
in the half-time of decline of the light and tension responses
was also characteristic of amrinone, indicating that the rate
of sequestration of Ca + + from the sarcoplasm was in-
creased. The combination of changes produced by amrinone
was distinctively different from that of the other inotropic
agents studied (40).
Clinical implications. In general, drugs that increase
developed tension produce a corresponding increase in the
amplitude of the intracellular Ca + + transient, although the
relative degree to which light is increased compared with
tension varies considerably among the major classes of in-
otropic agents (12). Previous research (12,38) has shown
that for a given increase in peak tension, isoproterenol
produces a greater increase in peak light than theophylline.
This apparent discrepancy in the ability of a given intra-
cellular Ca + + concentration to generate tension can be cor-
related with results obtained in skinned cardiac muscle prep-
arations, which show that pharmacological agents (43,45,49)
and stretch (58) can alter the Ca + + -sensitivity of the my-
ofilaments. Isoproterenol decreases and theophylline in-
creases the ability of the myofilaments to generate tension
at any given Ca + + concentration. These findings are im-
portant with regard to studies with aequorin in muscle cells
because, in some circumstances, the ratio between changes
in peak light and peak tension development can be used as
an index for changes in the sensitivity of the contractile
elements to Ca + + . One additional factor that must be kept
in mind is that drug-induced changes in the time course of
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the Ca+ + transient (Fig. 4 and 6) could affect the time of
contact between ICa+ + ]i and troponin-C; it is not possible
to assess the relative importanceof this effect at the present
time.
Of note is the finding that the light and tension responses
in human cardiac muscle are similar to those obtained in
lowermammals, particularly the cat, which has beenstudied
extensively. This suggests that many of the results obtained
using cardiac muscle from experimental mammalian prep-
arations can be extrapolated to human beings with validity.
The ability to correlate changes in the amplitudes and time
courses of the aequorin light signals and tension responses
with known subcellular actions of drugs provides an im-
portant tool for studyingthe effects of pharmacologic agents
on the heart (39). Furthermore, it should be possible to use
aequorin to determinewhether pathophysiologic states such
as ischemia or hypertrophy are associated with disorders in
intracellular Ca+ + handling. Preliminary studies by one of
us (l .P.M.) using muscle obtained from patients with hy-
pertrophy suggest that abnormalities in the Ca+ + transient
are in fact present. Studies of this sort should allow the
development of more rational therapeutics based on a more
complete understanding of pathophysiologic abnormalities
on the subcellular level that occur in intact and actively
contracting cardiac muscle cells.
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